Skip to content

Neurochemical Research

ISSN 1573-6903

11 papers in the library · 73 citations · publishing 1977-2026

Papers

Sort Most recent Most cited

The Potential of Cannabidiol for the Treatment of Psychosis: Endocannabinoid Regulation of Serotonergic Neurotransmission via Serotonin 5-HT1A/2A Receptors.

Neurochemical Research August 27, 2026 Kazutoshi Yonemura, Nobue Kitanaka, Kazuo Tomita et al.

Cannabis, widely used for both medical and non-medical purposes, primarily contains Δ9-tetrahydrocannabinol (Δ9-THC) and cannabidiol (CBD). Δ9-THC is the main driver of cannabis abuse and of psychological and physical dependence, whereas CBD has limited abuse potential and is even being investigated as a treatment for cannabis use disorder and other conditions. This review aims to clarify how...

Δ9-Tetrahydrocannabinol Modulates Hippocampal Neurogenesis in Female Wistar Rats: Interaction with Estradiol.

Neurochemical Research August 8, 2026 Duarte R Carvalhinho, Sandra I Marques, Sandra Leal et al.

The endocannabinoid system (ECS) plays a key role in regulating neurogenesis and inflammatory processes in the brain. The increasing prevalence of Cannabis use among women highlights the importance of understanding sex-specific effects of cannabinoids, particularly in the context of hormonal interactions. This study aimed to investigate the effects of delta-9-tetrahydrocannabinol (THC) and...

Glutathione as a Potential Neuroprotectant Against MDMA-Induced Oxidative Stress, Neuroinflammation, and Apoptosis in the Rat Brain.

Neurochemical Research May 6, 2026 Oyedayo Phillips Akano, Goodness Olatinwo, Moses Agbomhere Hamed et al.

3,4-Methylenedioxymethamphetamine (MDMA), widely misused for its euphoric and stimulant properties, induces overt neurotoxicity in rodents and non-human primates and is associated with profound neurochemical and structural brain alterations. Its deleterious effects are primarily mediated through oxidative stress, neuroinflammatory responses, and apoptotic pathways. Glutathione, a crucial...

DOI: 10.1007/s11064-026-04764-0 (opens in new tab) Full text (opens in new tab) Ecstasy Antioxidant therapy Chronic oral exposure Hippocampal injury +2

Esketamine Suppresses Astrocyte-Driven Neuroinflammation in Traumatic Brain Injury via the METTL5/c-Myc/PD-L1

Neurochemical Research March 13, 2026 Lan Luo, Miao Yu, Xiaodong Li et al.

Traumatic brain injury (TBI) is a major global health issue leading to high mortality and disability. Activated astrocytes are one of the pivotal driving factors in the neuroinflammatory cascade following TBI. This study aims to investigate the role of esketamine on TBI and the underlying mechanism. Mice received a mouse weight-drop cortical impact or sham surgery and TBI mice were treated with...

DOI: 10.1007/s11064-026-04724-8 (opens in new tab) Full text (opens in new tab) Neuroinflammation Astrocyte Traumatic brain injury Neuroprotection +7

The Missing Piece? A Case for Microglia's Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics.

Neurochemical Research April 1, 2023 Jared VanderZwaag, Torin Halvorson, Kira Dolhan et al. 25 citations

There is much excitement surrounding recent research of promising, mechanistically novel psychotherapeutics - psychedelic, anesthetic, and dissociative agents - as they have demonstrated surprising efficacy in treating central nervous system (CNS) disorders, such as mood disorders and addiction. However, the mechanisms by which these drugs provide such profound psychological benefits are still...

Resident Astrocytes can Limit Injury to Developing Hippocampal Neurons upon THC Exposure.

Neurochemical Research April 1, 2023 Maria Krassnitzer, Brooke Boisvert, Johannes Beiersdorf et al.

Cannabis legalization prompted the dilemma if plant-derived recreational drugs can have therapeutic potential and, consequently, how to address their regulation and safe distribution. In parallel, the steady worldwide decriminalization of cannabis and the enhanced content of its main psychoactive compound Δ9-tetrahydrocannabinol (THC), exposes populations to increasing amounts of cannabis and...

Muscimol as an ionotropic GABA receptor agonist.

Neurochemical Research October 1, 2014 Graham A R Johnston

Muscimol, a psychoactive isoxazole from Amanita muscaria and related mushrooms, has proved to be a remarkably selective agonist at ionotropic receptors for the inhibitory neurotransmitter GABA. This historic overview highlights the discovery and development of muscimol and related compounds as a GABA agonist by Danish and Australian neurochemists. Muscimol is widely used as a ligand to probe...

Oxidative stress in rat retina and hippocampus after chronic MDMA ('ecstasy') administration.

Neurochemical Research July 2007 María Miranda, Francisco Bosch-Morell, Siv Johnsen-Soriano et al.

The effects of MDMA administration on oxidative stress markers in rat eye and hippocampus, and the neuroprotective effects of the antioxidant 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6) have been studied. MDMA effects on liver were used for comparison with those in eye and hippocampus and to test CR-6 protective effects. Another goal was to test for apoptosis in retinal...

Long-lasting ibogaine protection against NMDA-induced convulsions in mice.

Neurochemical Research August 1, 2000 M B Leal, D O De Souza, E Elisabetsky 23 citations

Ibogaine, a putative antiaddictive drug, is remarkable in its apparent ability to downgrade withdrawal symptoms and drug craving for extended periods of time after a single dose. Ibogaine acts as a non-competitive NMDA receptor antagonist, while NMDA has been implicated in long lasting changes in neuronal function and in the physiological basis of drug addiction. The purpose of this study was...

DOI: 10.1023/a:1007665911622 (opens in new tab) Full text (opens in new tab) Ibogaine: ibogaine Drug withdrawal Craving Neuropharmacology: brain receptors +6

Effect of ibogaine on serotonergic and dopaminergic interactions in striatum from mice and rats.

Neurochemical Research November 1, 1994 Henry Sershen, Audrey Hashim, Ábel Lajtha 23 citations

The effect of ibogaine (Endabuse, NIH 10567) on serotonin uptake and release, and on serotonergic modulation of dopamine release, was measured in striatal tissue from rats and mice. Two hours after treatment in vivo with ibogaine (40 mg/kg i.p.) the uptake of labeled [3H]serotonin and [3H]dopamine uptake in striatal tissue was similar in the ibogaine-treated animal to that in the control. The...

Regional localization of [14C]mescaline in rabbit brain after intraventricular administration

Neurochemical Research June 1, 1977 Nandkumar S. Shah, O. D. Dulati, D. A. Powell et al. 2 citations

Albino rabbits of either sex were anesthetized, and a cannula was implanted permanently into the lateral ventricle. About 1 week later, the distribution of [(14)C]mescaline and its deaminated metabolite, [(14)C]trimethoxyphenylacetic acid ([(14)C]TMPA) in 12 brain regions was examined at 15, 60, and 180 min after the intraventricular injection of [(14)C]mescaline (0.5 μmol in 0.05 ml...

DOI: 10.1007/bf00969357 (opens in new tab) Mescaline Cerebrum Medulla oblongata Pons +7